Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Lestaurtinib FLT3 inhibitory activity is modulated by concomitant azole therapy and may Influence relapse risk

Knapper, Steven ORCID: https://orcid.org/0000-0002-6405-4441, Burnett, Alan Kenneth, Hills, Robert Kerrin ORCID: https://orcid.org/0000-0003-0166-0062, Small, Donald and Levis, Mark 2009. Lestaurtinib FLT3 inhibitory activity is modulated by concomitant azole therapy and may Influence relapse risk. Blood -New York- 114 (22) , p. 326.

Full text not available from this repository.
Item Type: Article
Date Type: Publication
Status: Published
Schools: Medicine
Subjects: R Medicine > R Medicine (General)
R Medicine > RC Internal medicine
Additional Information: 51st Annual Meeting of the American-Society-of-Hematology Location: New Orleans, LA Date: DEC 05-08, 2009
Publisher: American Society of Hematology
ISSN: 0006-4971
Last Modified: 24 Oct 2022 11:55
URI: https://orca.cardiff.ac.uk/id/eprint/49758

Citation Data

Actions (repository staff only)

Edit Item Edit Item